Prab: CSV import

2025-03-17T13:41:43Z

CSV import

← Older revision		Revision as of 13:41, 17 March 2025
Line 19:		Line 19:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T16:15:51Z

CSV import

← Older revision		Revision as of 16:15, 10 February 2025
Line 18:		Line 18:

	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-04-13T21:04:10Z

CSV import

New page

'''Granulocyte colony-stimulating factor receptor''' (G-CSFR) is a [[cell surface receptor]] that specifically binds and responds to the [[granulocyte colony-stimulating factor]] (G-CSF), a [[cytokine]] that plays a crucial role in the production, differentiation, and function of [[granulocyte]]s, a category of [[white blood cells]] (WBCs) involved in the immune response. The G-CSFR is encoded by the ''CSF3R'' gene in humans.

==Structure==
The G-CSFR is a member of the cytokine receptor family and is characterized by a modular structure that includes an extracellular domain, which binds G-CSF, a single [[transmembrane domain]], and an intracellular domain, which initiates [[signal transduction]] pathways upon ligand binding. The extracellular domain contains the cytokine receptor homology domain (CRH) necessary for binding G-CSF, while the intracellular domain is responsible for activating downstream signaling cascades that influence cell survival, proliferation, and differentiation.

==Function==
The primary function of the G-CSFR is to mediate the effects of G-CSF. G-CSF is a critical growth factor involved in the regulation of neutrophil production and function. Neutrophils are a type of granulocyte that plays a key role in the innate immune response by defending the body against bacterial and fungal infections. Upon binding to G-CSF, the G-CSFR activates several intracellular signaling pathways, including the [[JAK/STAT pathway]], the [[Ras/MAPK pathway]], and the [[PI3K/Akt pathway]]. These pathways contribute to various cellular processes such as survival, proliferation, differentiation, and function of neutrophils and their precursors.

==Clinical Significance==
Mutations in the ''CSF3R'' gene, which encodes the G-CSFR, have been associated with various hematological disorders, including severe congenital neutropenia (SCN) and chronic neutrophilic leukemia (CNL). SCN is characterized by a marked decrease in circulating neutrophils, leading to increased susceptibility to infections. CNL is a type of cancer that results in the overproduction of neutrophils. Therapeutically, recombinant human G-CSF (rhG-CSF) is used to treat neutropenia by stimulating the production of neutrophils through the activation of G-CSFR. This treatment is beneficial for patients undergoing chemotherapy, which often leads to neutropenia, thereby increasing the risk of infections.

==Research Directions==
Research on G-CSFR continues to explore its role in the immune system and its potential as a therapeutic target for treating various conditions associated with abnormal granulocyte function or production. Understanding the detailed mechanisms of G-CSFR signaling and its regulation may lead to the development of new therapeutic strategies for managing neutropenia and other related disorders.

[[Category:Immune system]]
[[Category:Cell biology]]
[[Category:Receptors]]

{{medicine-stub}}

Granulocyte colony-stimulating factor receptor - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import